Reset filter
Keywords
Clinical Chemistry Tests ×
Blood Pressure ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

6 Search results.

Relevance Rating New first Old first

The effect of intranasal capsaicin challenge model in healthy volunteers - 111611 - Period 2

- 3/13/19 - 1 form, 12 itemgroups, 87 items, 2 languages
Itemgroups: Administrative data,Investigational Product (Dose),Vital Signs (Dosing),Temperature (Dosing),Hematology (Dosing),Clinical Chemistry,Electrocardiogram,Peak Nasal Inspiratory Flow Rate,Total Symptom Score,Visual Analogue Scale,Nostril Secretions,Pharmacokinetics - Blood
Study ID: 111611 Clinical Study ID: 111611 Study Title: A randomised, double-blind, placebo-controlled study to assess the effect of oral, single dose SB-705498 in a validated intranasal capsaicin challenge model in healthy volunteers. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00731250 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: SB-705498, Placebo, Caspaicin Trade Name: N/A Study Indication: Rhinitis

Pharmacokinetics of an oral contraceptive co-administered with Albiglutide in women - 107032 - Early Term Data: Vital Signs, Physical Examination, ECG, Laboratory Tests

- 12/28/18 - 1 form, 9 itemgroups, 55 items, 1 language
Itemgroups: Administrative data,Vital Signs - Duplicate 1,Vital Signs - Duplicate 2,Physical Examination,Electrocardiogram,Overall Interpretation of ECG,Hematologic Test,Chemistry Test,UA / Urine Chemistry Test
Study ID: 107032 Clinical Study ID: GLP107032 Study Title: An open-label study to evaluate the pharmacokinetics of an oral contraceptive containing Norethindrone and Ethinyl Estradiol when co-administered with GSK716155 in healthy adult female subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01077505 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: albiglutide Trade Name: Tanzeum,Eperzan Study Indication: Diabetes Mellitus, Type 2

Pharmacokinetics of an oral contraceptive co-administered with Albiglutide in women - 107032 - Period 2 Day 18 + Day 19 + Day 20

- 12/27/18 - 1 form, 21 itemgroups, 112 items, 1 language
Itemgroups: Administrative data,Day 18,Vital Signs - Duplicate 1,Vital Signs - Duplicate 2,Study Drug Administration,Day 19,Vital Signs - Duplicate 1,Vital Signs - Duplicate 2,Study Drug Administration,Study Drug Administration 2 ,Pharmacokinetic Blood Collection,Day 20,Vital Signs - Duplicate 1,Vital Signs - Duplicate 2,Electrocardiogram,Overall Interpretation of ECG,Study Drug Administration,Hematologic Test,Chemistry Test,UA/Urine Chemistry,Pharmacokinetic Blood Collection
Study ID: 107032 Clinical Study ID: GLP107032 Study Title: An open-label study to evaluate the pharmacokinetics of an oral contraceptive containing Norethindrone and Ethinyl Estradiol when co-administered with GSK716155 in healthy adult female subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01077505 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: albiglutide Trade Name: Tanzeum,Eperzan Study Indication: Diabetes Mellitus, Type 2

Pharmacokinetics of an oral contraceptive co-administered with Albiglutide in women - 107032 - Period 2 Day 1 + Day 5

- 12/27/18 - 1 form, 15 itemgroups, 80 items, 1 language
Itemgroups: Administrative data,Day 1,Vital Signs - Duplicate 1,Vital Signs - Duplicate 2,Study Drug Administration,Hematology Test,Chemistry,UA / UDS / Urine HCG / Urine Chemistry,Pharmacodynamic Blood Collection,Pharmacodynamic Blood Collection 2,Day 5,Vital Signs - Duplicate 1,Vital Signs - Duplicate 2,Study Drug Administration,Study Drug Administration 2
Study ID: 107032 Clinical Study ID: GLP107032 Study Title: An open-label study to evaluate the pharmacokinetics of an oral contraceptive containing Norethindrone and Ethinyl Estradiol when co-administered with GSK716155 in healthy adult female subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01077505 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: albiglutide Trade Name: Tanzeum,Eperzan Study Indication: Diabetes Mellitus, Type 2

Pharmacokinetics of an oral contraceptive co-administered with Albiglutide in women - 107032 - Period 1 Day 20-21 (Visit 140-150): Vital Signs, Drug Administration, ECG, Laboratory Tests

- 12/24/18 - 1 form, 18 itemgroups, 91 items, 1 language
Itemgroups: Administrative data,Vital Signs,Duplicate 1,Duplicate 2,Study Drug Administration,Hematology Test,Chemistry Test,UA / Urine Chemistry Test,Pharmacokinetic Blood Collection,Period 1 - Day 21,Vital Signs,Duplicate 1,Duplicate 2,Electrocardiogram,Overall Interpretation of ECG,Study Drug Administration,Pharmacodynamic Blood Connection,Pharmacokinetic Blood Collection 12 hr span
Study ID: 107032 Clinical Study ID: GLP107032 Study Title: An open-label study to evaluate the pharmacokinetics of an oral contraceptive containing Norethindrone and Ethinyl Estradiol when co-administered with GSK716155 in healthy adult female subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01077505 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: albiglutide Trade Name: Tanzeum,Eperzan Study Indication: Diabetes Mellitus, Type 2

Pharmacokinetics of an oral contraceptive co-administered with Albiglutide in women - 107032 - Run-In Day 21 (Visit 70)

- 12/21/18 - 1 form, 5 itemgroups, 31 items, 1 language
Itemgroups: Administrative data,Vital Signs,Chemistry / SP Chemistry,Pharmacodynamic Blood Collection,Pharmacodynamic Blood Collection
Study ID: 107032 Clinical Study ID: GLP107032 Study Title: An open-label study to evaluate the pharmacokinetics of an oral contraceptive containing Norethindrone and Ethinyl Estradiol when co-administered with GSK716155 in healthy adult female subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01077505 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: albiglutide Trade Name: Tanzeum,Eperzan Study Indication: Diabetes Mellitus, Type 2

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial